Akero Therapeutics Inc (AKRO) Up 1.84% in Premarket Trading

Akero Therapeutics Inc (AKRO) is higher by Friday morning, with the stock gaining 1.84% in pre-market trading to 14.96. AKRO's short-term technical score of 4 indicates that the stock has traded less bullishly over the last month than 96% of stocks on the market. In the Biotechnology industry, which ranks 136 out of 146 industries, AKRO ranks higher than 9% of stocks. Akero Therapeutics Inc has fallen 70.57% over the past month, closing at $52.24 on September 15. During this period of time, the stock fell as low as $15.04 and as high as $53.77. AKRO has an average analyst recommendation of Strong Buy. The company has an average price target of $51.00.

AKRO has an Overall Score of 25. Find out what this means to you and get the rest of the rankings on AKRO!

See Full AKRO Report

Akero Therapeutics Inc has a Long-Term Technical rank of 0. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 100% of the market scoring higher. In the Biotechnology industry which is number 138 by this metric, AKRO ranks better than 138% of stocks.

Important Dates for Investors in AKRO:

-Akero Therapeutics Inc is set to release earnings on 2023-11-03. Over the last 12 months, the company has reported EPS of $-2.51. -We do not have a set dividend date for Akero Therapeutics Inc at this time. Click Here To Get The Full Report on Akero Therapeutics Inc (AKRO)